VECTOR SCIENCE AND THERAPEUTICS CORP.

Ajouter à une liste

Communiqués Vector Science and Therapeutics Corp.

Actions

PAIN

CA92244M1041

Sociétés holdings

Temps Différé Toronto S.E. Autres places de cotation 19:37:34 30/07/2026			Varia. 5j.	Varia. 1 janv.
1,550 ^CAD	+1,97 %		-0,64 %	+3 000,00 %

28/07	Vector Science & Therapeutics Corp., LyoGenesis Plus 1, LLC et Wynn Pharmaceuticals LLC annoncent une collaboration stratégique pour le développement et la fabrication de produits médicaux de soins critiques	CI
21/07	Vector Science va mettre en place un réseau de distribution pour la commercialisation de son portefeuille de peptides	MT

Communiqués

27/07	Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28	AQ
25/07	Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28	AQ
21/07	Vector Science & Therapeutics Announces Distributor Network Buildout to Support Its Peptide Portfolio Across Orthopedic, Sports, and Regenerative Medicine Channels	AQ
17/07	Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist	AQ
15/07	Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies	AQ
07/07	Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio	AQ
30/06	Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform	AQ
22/06	Gary Payton II Named Chief Athletic Ambassador of Valor	AQ
15/06	Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform	AQ
12/06	Vector Science & Therapeutics Names Dexter Fowler as Chief Athletic Officer for Its Valor Platform	AQ
08/06	Vector Science & Therapeutics Appoints Darryl Drake Jr. as President of Valor	AQ
02/06	Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy	AQ
13/05	Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing	AQ
11/05	/C O R R E C T I O N -- Vector Sciences & Therapeutics/	AQ
06/05	Vector Science & Therapeutics Expands Board of Directors with Appointment of Dr. Alexander Dobranowski and Scott Kelly	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Espace mes listes

Palmarès

Suite du Palmarès

Palmarès

Suite du Palmarès

Devises / Forex

Matières Premières

Cryptomonnaies

Taux d'Intérêts

Bourse
Actions
Action PAIN
Actualités Vector Science and Therapeutics Corp.
Communiqués

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !

🔇